161 related articles for article (PubMed ID: 14530605)
1. Pilot study of elevated levels of insulin-like growth factor-binding protein-2 as indicators of hepatocellular carcinoma.
Ranke MB; Maier KP; Schweizer R; Stadler B; Schleicher S; Elmlinger MW; Flehmig B
Horm Res; 2003; 60(4):174-80. PubMed ID: 14530605
[TBL] [Abstract][Full Text] [Related]
2. Serum IGF-1, IGF-2 and IGFBP-3 as parameters in the assessment of liver dysfunction in patients with hepatic cirrhosis and in the diagnosis of hepatocellular carcinoma.
Rehem RN; El-Shikh WM
Hepatogastroenterology; 2011; 58(107-108):949-54. PubMed ID: 21830422
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of insulin-like growth factor-I, -II and insulin-like growth factor binding proteins -2 and -3 in children with acute lymphoblastic leukaemia.
Mohnike KL; Kluba U; Mittler U; Aumann V; Vorwerk P; Blum WF
Eur J Pediatr; 1996 Feb; 155(2):81-6. PubMed ID: 8775218
[TBL] [Abstract][Full Text] [Related]
4. The insulin-like growth factor-1 and expression of its binding protein‑3 in chronic hepatitis C and hepatocellular carcinoma.
Adamek A; Kasprzak A; Mikoś H; Przybyszewska W; Seraszek-Jaros A; Czajka A; Sterzyńska K; Mozer-Lisewska I
Oncol Rep; 2013 Sep; 30(3):1337-45. PubMed ID: 23784592
[TBL] [Abstract][Full Text] [Related]
5. Serum insulin-like growth factor-II and alpha-fetoprotein as tumor markers of hepatocellular carcinoma.
Tsai JF; Jeng JE; Chuang LY; You HL; Ho MS; Lai CS; Wang LY; Hsieh MY; Chen SC; Chuang WL; Lin ZY; Yu ML; Dai CY
Tumour Biol; 2003; 24(6):291-8. PubMed ID: 15004489
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer.
Renehan AG; Jones J; Potten CS; Shalet SM; O'Dwyer ST
Br J Cancer; 2000 Nov; 83(10):1344-50. PubMed ID: 11044360
[TBL] [Abstract][Full Text] [Related]
7. Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure.
Frystyk J; Ivarsen P; Skjaerbaek C; Flyvbjerg A; Pedersen EB; Orskov H
Kidney Int; 1999 Dec; 56(6):2076-84. PubMed ID: 10594783
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum levels of IGF-binding protein 2 in patients with non-seminomatous germ cell cancer: correlation with tumor markers alpha-fetoprotein and human chorionic gonadotropin.
Fottner C; Sattarova S; Hoffmann K; Spöttl G; Weber MM
Eur J Endocrinol; 2008 Sep; 159(3):317-27. PubMed ID: 18524796
[TBL] [Abstract][Full Text] [Related]
9. Serum insulin-like growth factor-II as a serologic marker of small hepatocellular carcinoma.
Tsai JF; Jeng JE; Chuang LY; You HL; Wang LY; Hsieh MY; Chen SC; Chuang WL; Lin ZY; Yu ML; Dai CY
Scand J Gastroenterol; 2005 Jan; 40(1):68-75. PubMed ID: 15841717
[TBL] [Abstract][Full Text] [Related]
10. Paradoxical elevations in serum IGF-II and IGF binding protein-2 in acromegaly: insights into the regulation of these peptides.
Renehan AG; Toogood AA; Ryder WD; Jones J; Potten CS; O'Dwyer ST; Shalet SM
Clin Endocrinol (Oxf); 2001 Oct; 55(4):469-75. PubMed ID: 11678829
[TBL] [Abstract][Full Text] [Related]
11. Increased levels of insulin-like growth factor binding protein-2 in sera and tumours from patients with colonic neoplasia with and without acromegaly.
Miraki-Moud F; Jenkins PJ; Fairclough PD; Jordan S; Bustin SA; Jones AM; Lowe DG; Monson JP; Grossman AB; Besser GM; Camacho-Hübner C
Clin Endocrinol (Oxf); 2001 Apr; 54(4):499-508. PubMed ID: 11318786
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factors and their binding proteins before and after weight loss and their associations with hormonal and metabolic parameters in obese adolescent girls.
Wabitsch M; Blum WF; Muche R; Heinze E; Haug C; Mayer H; Teller W
Int J Obes Relat Metab Disord; 1996 Dec; 20(12):1073-80. PubMed ID: 8968852
[TBL] [Abstract][Full Text] [Related]
13. Free and total insulin-like growth factor (IGF)-I, -II, and IGF binding protein-1, -2, and -3 serum levels in patients with active thyroid eye disease.
Krassas GE; Pontikides N; Kaltsas T; Dumas A; Frystyk J; Chen JW; Flyvbjerg A
J Clin Endocrinol Metab; 2003 Jan; 88(1):132-5. PubMed ID: 12519841
[TBL] [Abstract][Full Text] [Related]
14. A phase II study of cixutumumab (IMC-A12, NSC742460) in advanced hepatocellular carcinoma.
Abou-Alfa GK; Capanu M; O'Reilly EM; Ma J; Chou JF; Gansukh B; Shia J; Kalin M; Katz S; Abad L; Reidy-Lagunes DL; Kelsen DP; Chen HX; Saltz LB
J Hepatol; 2014 Feb; 60(2):319-24. PubMed ID: 24045151
[TBL] [Abstract][Full Text] [Related]
15. Increased IGF-I : IGFBP-3 ratio in patients with hepatocellular carcinoma.
Mattera D; Capuano G; Colao A; Pivonello R; Manguso F; Puzziello A; D'Agostino L
Clin Endocrinol (Oxf); 2003 Dec; 59(6):699-706. PubMed ID: 14974910
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factors and insulin-like growth factor binding proteins in adult patients with severe liver disease before and after orthotopic liver transplantation.
Weber MM; Auernhammer CJ; Lee PD; Engelhardt D; Zachoval R
Horm Res; 2002; 57(3-4):105-12. PubMed ID: 12006706
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
Arosio M; Garrone S; Bruzzi P; Faglia G; Minuto F; Barreca A
J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
[TBL] [Abstract][Full Text] [Related]
18. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
Heald A; Kaushal K; Anderson S; Redpath M; Durrington PN; Selby PL; Gibson MJ
Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358
[TBL] [Abstract][Full Text] [Related]
19. Serum insulin-like growth factor I (IGF-I), IGF-binding proteins 2 and 3, and the risk for development of malignancies in adults with growth hormone (GH) deficiency treated with GH: data from KIMS (Pfizer International Metabolic Database).
Popovic V; Mattsson AF; Gaillard RC; Wilton P; Koltowska-Häggström M; Ranke MB
J Clin Endocrinol Metab; 2010 Sep; 95(9):4449-54. PubMed ID: 20610598
[TBL] [Abstract][Full Text] [Related]
20. Serum insulin-like growth factor-I level is an independent predictor of recurrence and survival in early hepatocellular carcinoma: a prospective cohort study.
Cho EJ; Lee JH; Yoo JJ; Choi WM; Lee MJ; Cho Y; Lee DH; Lee YB; Kwon JH; Yu SJ; Lee JM; Suh KS; Kim K; Kim YJ; Yoon JH; Kim CY; Lee HS
Clin Cancer Res; 2013 Aug; 19(15):4218-27. PubMed ID: 23757355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
